Share
    NEW SEARCH RETURN TO SEARCH RESULTS
Number: 201011820 Principal Investigator: Tan, Benjamin
Title: Protocol I4T-MC-JVBB (also known as IMCL CP12 0920) A Randomized, Double-Blind, Multicenter Phase 3 Study of Irinotecan, Folinic Acid, and 5-Fluorouracil (FOLFIRI) Plus Ramucirumab or Placebo in Patients With Metastatic Colorectal Carcinoma Progressive During or Following First-Line Combination Therapy With Bevacizumab, Oxaliplatin, and a Fluoropyrimidine
Phase: III Disease Site: Colon
Participating Site(s):
 
Main Campus
Map and Directions		 South County
Map and Directions		 St. Peters
Map and Directions		 West County
Map and Directions
 
Contact: 800-600-3606 or info@ccadmin.wustl.edu
Description:
The purpose of this research study is to see how safe an investigational drug called ramucirumab is and to see how well it helps people with colon cancer.

The primary purpose of this study is to help answer the following research questions:

Can ramucirumab help patients with colon cancer live longer?

What can we learn about the safety of ramucirumab?
 
More Information:
ClinicalTrials.gov Link
Internal Protocol Documents (requires Siteman administrative database password)